GSK3β (glycogen synthase kinase 3β) is involved in the phosphorylation of various important regulatory proteins. Pharmacological inhibition of this enzyme could yield treatments for a variety of diseases including diabetes and Alzheimer's disease. The understanding of events involved in the molecular recognition of inhibitors by the active site of this enzyme is key in structure-based design strategies. The present study deals with the dynamic nature of GSK3β and highlights the importance of studying protein plasticity in structure-based drug design, exemplified by our method called ASP (active-site pressurization).
Exploiting glycogen synthase kinase 3β flexibility in molecular recognition
Michael P. Mazanetz, Ian M. Withers, Charles A. Laughton, Peter M. Fischer; Exploiting glycogen synthase kinase 3β flexibility in molecular recognition. Biochem Soc Trans 1 February 2008; 36 (1): 55–58. doi: https://doi.org/10.1042/BST0360055
Download citation file: